Plain-English translation of NCT06099730 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new procedure called pulsed field ablation using the VARIPULSE catheter and TRUPULSE generator to treat atrial fibrillation—a condition where your heart's upper chambers beat irregularly. The procedure aims to isolate the pulmonary veins (where most irregular beats start) and parts of the back wall of the heart chamber. Researchers want to make sure this treatment is safe and works well for at least 12 months after the procedure.
Atrial fibrillation affects millions of people and can cause serious complications, but current treatment options have limitations. This new energy-based technique may offer a safer, more effective way to correct irregular heartbeats without the side effects of some existing treatments.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo the pulsed field ablation procedure at Massachusetts General Hospital. You'll then return for scheduled follow-up visits and tests over 12 months to check that the procedure worked and to monitor for any side effects. The study team will track your heart rhythm, symptoms, and overall health during this time using heart monitors, imaging, and office visits.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States